Our top pick for
Misonix, Inc is a medical devices business based in the US. Misonix shares (MSON) are listed on the NASDAQ and all prices are listed in US Dollars. Misonix employs 254 staff and has a trailing 12-month revenue of around USD$69.1 million.
|Latest market close||USD$12.8|
|52-week range||USD$6.71 - USD$20.4|
|50-day moving average||USD$12.4817|
|200-day moving average||USD$12.9257|
|Wall St. target price||USD$20|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.791|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-11)||-2.88%|
|1 month (2020-12-18)||-7.51%|
|3 months (2020-10-16)||2.48%|
|6 months (2020-07-17)||-7.85%|
|1 year (2020-01-17)||-34.46%|
|2 years (2019-01-18)||-27.93%|
|3 years (2018-01-18)||37.63%|
|5 years (2016-01-15)||48.84%|
|Revenue TTM||USD$69.1 million|
|Gross profit TTM||USD$43.7 million|
|Return on assets TTM||-5.57%|
|Return on equity TTM||-17.68%|
|Market capitalisation||USD$237 million|
TTM: trailing 12 months
There are currently 473,938 Misonix shares held short by investors – that's known as Misonix's "short interest". This figure is 4.3% down from 495,393 last month.
There are a few different ways that this level of interest in shorting Misonix shares can be evaluated.
Misonix's "short interest ratio" (SIR) is the quantity of Misonix shares currently shorted divided by the average quantity of Misonix shares traded daily (recently around 30935.90078329). Misonix's SIR currently stands at 15.32. In other words for every 100,000 Misonix shares traded daily on the market, roughly 15320 shares are currently held short.
However Misonix's short interest can also be evaluated against the total number of Misonix shares, or, against the total number of tradable Misonix shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Misonix's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Misonix shares in existence, roughly 30 shares are currently held short) or 0.0392% of the tradable shares (for every 100,000 tradable Misonix shares, roughly 39 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Misonix.
Find out more about how you can short Misonix stock.
We're not expecting Misonix to pay a dividend over the next 12 months.
Misonix's shares were split on a 3:2 basis on 21 October 1997. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Misonix shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Misonix shares which in turn could have impacted Misonix's share price.
Over the last 12 months, Misonix's shares have ranged in value from as little as $6.71 up to $20.4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Misonix's is 1.4481. This would suggest that Misonix's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets minimally invasive surgical ultrasonic medical devices in the United States and internationally. The company's products include BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, general surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.
Everything we know about the Gold Royalty Corp IPO, plus information on how to buy in.
Everything we know about the Bustle Digital Group IPO, plus information on how to buy in.
Everything we know about the Lucid Motors IPO, plus information on how to buy in.
Steps to owning and managing HFFG, with 24-hour and historical pricing before you buy.
Steps to owning and managing HASI, with 24-hour and historical pricing before you buy.
Steps to owning and managing GRIF, with 24-hour and historical pricing before you buy.
Steps to owning and managing FSBW, with 24-hour and historical pricing before you buy.
Steps to owning and managing FNWB, with 24-hour and historical pricing before you buy.
Steps to owning and managing FXNC, with 24-hour and historical pricing before you buy.
Steps to owning and managing FMNB, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.